Don't miss out on the latest news, evidence and CPD opportunities on medicines and medical tests - sign up today.
You have not selected any filters.
Confidently recognise when low back pain requires further investigation and identify patients at risk of chronic, disabling pain.
Discusses QUM principles around stopping medicines, with PPIs for GORD used to illustrate when to review and how to step down or stop therapy safely and effectively.
How would you advise a patient with well-controlled gastro-oesophageal reflux disease (GORD) who would like to continue their proton pump inhibitor (PPI) therapy?
Use a stepwise approach to manage patients with COPD and individualise choice of inhaler based on patient-specific factors. This Clinical e-Audit requires data to be submitted for only SEVEN (7) patients.This activity is funded by Novartis Pharmaceuticals Australia Pty Ltd and managed through VentureWise, a wholly owned subsidiary of NPS MedicineWise. The content has been developed by NPS MedicineWise with complete independence and editorial control and is based on best practice guidelines.
Improve patient outcomes by using a stepwise approach to diagnosing neuropathic pain, and discover emerging evidence for first-line medicines. Due to the low prevalence of neuropathic pain, this Clinical e-Audit requires data to be submitted for only FIVE (5) patients.